Latest Anatara Lifesciences (ASX:ANR) News
Page 1
Page 1 of 2
Anatara flags funding uncertainty as AOC obesity project remains on hold
23 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Anatara Moves AOC Toward Manufacturing Without Another Clinical Trial
13 Oct 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Anatara Lifesciences Navigates Mixed Anti-Obesity Data and Tight Cash Position
29 Apr 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Anatara Lifesciences Halves Loss, Advances Anti-Obesity Research Amid $1.2m Capital Raise
25 Feb 2026
Anatara Lifesciences Unveils Promising Anti-Obesity Compound Amid $1.2M Capital Raise
30 Jan 2026
Anatara’s AOC Compound Shows Promise in Pre-Clinical Weight Control Study
17 Dec 2025
Anatara Lifesciences Finalises 66 Million Share Placement, Issues Options to Lead Manager
26 Nov 2025
Anatara Lifesciences Advances Anti-Obesity Trials, Secures $1.2M Placement
23 Oct 2025
Anatara Lifesciences Issues 33.6 Million Shares in First Placement Tranche
8 Oct 2025